Crumly & Associates Inc. Astrazeneca PLC Transaction History
Crumly & Associates Inc.
- $318 Million
- Q3 2024
A detailed history of Crumly & Associates Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Crumly & Associates Inc. holds 6,644 shares of AZN stock, worth $451,526. This represents 0.16% of its overall portfolio holdings.
Number of Shares
6,644
Previous 6,501
2.2%
Holding current value
$451,526
Previous $507,000
1.97%
% of portfolio
0.16%
Previous 0.16%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,351Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.27 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.85 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.53 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.5 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.3 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...